The Dark Lord
Unregistered
- Joined
- Jan 4, 2012
- Messages
- 1,859
In my experience, it is not hard at all to get a script except maybe opiate painkillers. Getting a script for Ambien is as easy as telling the doctor I'm having trouble sleeping.
That's no solice to the victims of these drugs.
But I'm getting repetitive.
In my experience, it is not hard at all to get a script except maybe opiate painkillers. Getting a script for Ambien is as easy as telling the doctor I'm having trouble sleeping.
The company never wrote any prescriptions and it's under different leadership now. Not that they shouldn't be fined, but the fines aren't to give solace to victims the fines are to keep companies in line.
Bills of these said costs belong to the costcenter of the legally intended use of the drugs, no?sales are not profits
(...)
minus the cost of research and development, marketing
It's still a pittance to them. They have still made a profit from their crimes. They can easily afford to pay it and carry on their business.
What the hell are you talking about? GSK will be able continue to carry on their business for decades.GSKs long term ability to carry on their business is questionable.
http://online.wsj.com/article/SB10001424052702303933404577505032006855076.html
Anyone heard of this Dr. Drew?
Bills of these said costs belong to the costcenter of the legally intended use of the drugs, no?
Again there are complex issues involved that go well beyond Big Pharma. It's the norm for drug companies to hire 'experts' as part of marketing.http://online.wsj.com/article/SB10001424052702303933404577505032006855076.html
Anyone heard of this Dr. Drew?
Actualy the rate of return on pharmacutical investments has been pretty poor over the last decade. Based on current trends and the falling number of new drugs appearing GSKs long term ability to carry on their business is questionable.
The debate continues, however, about whether or not there can be a healthy relationship between doctors and pharmaceutical companies, or whether we need an absolute wall of separation between the two. One recent article, for example, found that doctors who have no access to pharmaceutical reps were up to four times slower to adopt new medications than physicians with some access to reps. In addition, they were also four times slower to stop using a drug that has a new black box warning, meaning that negative information about safety has come to light. It seems, therefore, that pharmaceutical companies can be a useful conduit of information to physicians, but that also comes with a lot of baggage. It seems to me that we have two choices. Either we develop new ways of quickly spreading the word about new valuable drugs and new warnings about existing drugs (pushing critical information to physicians), and/or we need to carefully monitor and regulate the pharmaceutical company distribution of this information.
Well, I wouldn't call it a "pittance". $3bn actually seems like real money.
A "pittance" would be something like the $25,000 fine that Google received recently.
What the hell are you talking about? GSK will be able continue to carry on their business for decades.
Any fine which is lower than the profit you made illegally, is just "the cost of doing business" and it does not send the message to not do it again, it send the message that doing such bad stuff is perfectely fine, because even caught you will still have made lotta profit all counted.
It is actually more a tax on being caught than really an attempt at stopping any illegal stuff.
Like I was sayin'.Steven Novella covers this story in Science Base Medicine.
As usual its a bit more complicated than it might seem at first.....
I know in the UK there used to be a terrible problem with the drug companies bribing (by any other name) GPs to prescribe their drugs. It's much reduced these days but with the huge potential upside i.e. profit for the drug companies the incentive is still there for "under the counter" bribing.
There's a world of difference between testifying before congress in a custom made Armani suit and doing the perp walk for the 11 o' clock news in a standard issue orange jumpsuit. At least that's what Jack Abramoff says.Your alternative--jail time for the CEO, I suppose--is hardly a better option. CEOs have been dropping like flies lately or appearing in front of various committees to defend their activities but the corporations behind them appear to be doing just fine.
I was actually suggesting both--holding the reification, the drug company responsible by making them pay, and criminal charges for the individuals responsible.Your alternative--jail time for the CEO, I suppose--is hardly a better option.